cp wire

CP Wire Articles

First patient dosed in unique biomarker guided Ph III study of enzastaurin + R-CHOP in high-risk diffuse large B-cell lymphoma (DLBCL)

On 4/3/2018, Denovo Biopharma LLC, announced dosing of the first patient in its pivotal Phase 3 ENGINE trial.   The ENGINE trial is a global, randomized, double-blind, registrational study... read more

Wed, 04/4/18 - 08:26 am
Propeller Health uses digital data from inhalers to successfully reduce asthma symptoms in large-scale real world study

On 4/2/2018 Propeller Health and peer-reviewed healthcare journal, Health Affairs, published results from a cross-sector... read more

Tue, 04/3/18 - 12:31 pm
Results from Third of Three Pivotal Trials of Cariprazine in Bipolar I Depression Mostly Positive


Allergan plc (NYSE: AGN), a leading global pharmaceutical company, and Gedeon Richter Plc., today announced positive topline results for RGH-MD-53, a Phase 3 study of cariprazine for the... read more

Tue, 04/3/18 - 09:08 am
Citizen Petition Watch - Increased Activity Around Ditropan XL

There have been two citizen petitions (from two different companies) in the last two working days requesting that the FDA determine that Ditropan XL was not withdrawn from the market for reasons... read more

Mon, 04/2/18 - 05:25 pm
Healthcare on the Hill - Update - H.R.5298 a bill that would classify all opioid mu receptor agonists schedule I

The text of H.R. 5298 is now available. When we first saw the full title of this bill it appeared that it would, if passed, result in all opioids that act at mu receptor agonists being classified... read more

Mon, 04/2/18 - 02:40 pm

Pages